Gum treatment may ease arthritis inflammation, small study hints
NCT ID NCT05880303
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a deep cleaning of the gums (nonsurgical periodontal therapy) could lower inflammation and improve quality of life in 20 people who have both rheumatoid arthritis and gum disease. Researchers measured changes in immune markers, bacteria in the mouth, and arthritis activity. The goal is to see if treating gum disease might also help control rheumatoid arthritis.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- nonsurgical periodontal therapy (deep cleaning of gums)
- What this could lead to
- If successful, this could show that treating gum disease helps manage rheumatoid arthritis inflammation and improve daily life.
- What could go wrong
- This is a very small, early study with only 20 participants, so results may not apply to everyone. It looks at markers of disease, not a proven treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Jun 2023
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. All RA patients who fulfill the American College of Rheumatology (formerly the American Rheumatism Association) 2010 revised criteria for the classification of RA and who are unresponsive to conventional RA treatment. 2. At least 3 sites with probing pocket depths (PPD) ≥4mm and 4 sites with clinical attachment level (CAL) ≥4mm distributed in at least 2 quadrants (Papapanou et al, 2018) and will be designated as having Stage II and Stage III periodontitis 3. Patients should have a minimum of 12 teeth present. Exclusion Criteria: 1. Patients who are on antibiotic use during the previous 3 months before study 2. Patients who have received nonsurgical periodontal treatment within 4 months before the study. 3. Patients who have any concurrent systemic or debilitating conditions such as uncontrolled diabetes. 4. Non Malaysian subjects 5. Patients who are pregnant 6. Presence of acute dental pain or infections
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periodontitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universiti Malaya
Kuala Lumpur, Kuala Lumpur, 56100, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe why rheumatic pain feels different for everyone
- Could a pill replace an IV for gum surgery pain relief?
- Can everyday supplements boost gum disease therapy?
- Can pulling a loose tooth and putting it back save it?
- Gum fluid proteins eyed as link between smoking and periodontitis
- Gum fluid holds clues to Behçet's disease puzzle